Investor Relations

Management Team

Dr Metha image

Vimal Mehta, Ph.D.

Chief Executive Officer & Founder
Dr. Mehta brings over two decades of experience in the pharma and biotech industry, during which he has successfully designed and implemented innovative solutions, established global commercial operations, and led cross-functional teams. During his career, he has garnered a deep understanding of
Richard I. Steinhart

Richard I. Steinhart

Senior Vice President and Chief Financial Officer
Mr. Steinhart brings significant financial and strategic experience in the biotechnology and medical device industries. Prior to joining BioXcel Therapeutics, Richard served as Vice President and CFO at Remedy Pharmaceuticals, Inc., until it sold its only asset, CIRARA, to Biogen for $120M plus
Frank D. Yocca, Ph.D.

Frank D. Yocca, Ph.D.

Chief Scientific Officer
Dr. Yocca is an accomplished R&D executive and scientist with extensive experience leading global biopharmaceutical companies. He has wide-ranging expertise in leading high performance, world-class teams in drug discovery and development whose efforts have resulted in a number of prominent
Vincent J.O’Neill M.D.

Vincent J.O’Neill M.D.

Senior Vice President & Chief Medical Officer
Dr. O’Neill has proven expertise in therapeutic and diagnostic product development and has held senior leadership roles at global pharmaceutical companies, including Sanofi, Genentech and GlaxoSmithKline. Most recently, he served as Chief Medical Officer at Mirna Therapeutics and Exosome
Javier Rodriguez

Javier Rodriguez

Senior Vice President, Chief Legal Officer, and Corporate Secretary
Mr. Rodriguez has over 20 years of extensive strategic and legal experience within the biopharmaceutical industry. Prior to joining BioXcel Therapeutics, he served as Chief Legal Officer at Indivior PLC, where he oversaw all legal affairs, data privacy compliance and corporate governance matters
Matt Wiley

Matt Wiley

Senior Vice President and Chief Commercial Officer
Mr. Wiley has over 25 years of sales, marketing, and strategy experience across multiple specialty product launches. Prior to joining BioXcel Therapeutics, Mr. Wiley served as Chief Commercial Officer at VYNE Therapeutics, overseeing all commercial objectives related to the launch of the company’s